I am employed as a Senior Lecturer/Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust/University of Manchester, Division of Cancer Sciences.  My areas of research interest are in hepatopancreaticobiliary and neuroendocrine neoplasms and I have published work in these subject areas as well as others (Central Nervous System tumours in particular).  I lead and participate in clinical trials and serve on data safety monitoring and trial steering committees for national and international clinical trials.

I am also the current lead of The Christie NHS Foundation Trust European Neuroendocrine Tumour Society Centre of Excellence (2020 onwards).

I was appointed on July 1st 2014 as a Senior Lecturer/Honorary Consultant in Medical Oncology (University of Manchester/The Christie NHS Foundation Trust).  I treat patients with a diagnosis of hepatopancreaticobiliary malignancies and neuroendocrine neoplasms.  I did a 3 year clinical research fellowship in “Princess Margaret Cancer Centre”, Toronto, Canada (2011-2014) in Gastrointestinal tract cancers and Central Nervous System tumours.  I obtained my Certificate of Satisfactory completion of specialist training (Medical Oncology) from the Royal College of Physicians of Ireland.  I have Membership and Fellowship (2023) of the Royal College of Physicians of UK.  I also have a degree in Biochemistry and a PhD in Pharmacology (National University of Ireland, Galway).

Clinical and translational research in hepatopancreaticobiliary and neuroendocrine neoplasms; clinical trials, audit and meta-analysis.

I previously taught and acted as a tutor on the MRes in Oncology and taught on the MRes in Experimental Cancer Medicine programmes.

I supervise Medical student APEP projects and I also assess Year 3 MB ChB Applied PEP oral presentations (University of Manchester).

I was an academic advisor to Medical students at the University of Manchester from 2014 to 2022.

I interview for Medical student entry (UCAS), University of Manchester.

I co-supervise PhD students.

I am a Peer Review Assessor as part of the Peer Review College, University of Manchester, which sits at faculty level and is responsible for undertaking peer review of teaching and learning activities in the faculty.

New Academics Programme (NAP) Assessor.

Completed American Society of Clinical Oncology (ASCO) Education Scholar's Programme (ESP) 2019-2021 (following this term, participants are placed on an education-focused work group to integrate learning sciences into ASCO programmes).

International:

On American Society of Clinical Oncology (ASCO) Annual Meeting Education Committee: Gastrointestinal Cancer - Gastroesophageal, Pancreatic and Hepatobiliary Track (June 7, 2021 to June 3, 2024); Track Lead for 2024.

On ASCO Annual Meeting Scientific Committee: Gastrointestinal Cancer - Gastroesophageal, Pancreatic and Hepatobiliary Track (2024).

Member of ASCO ESMO Global Curriculum (for Medical Oncology) Working Group (2-year term from 2024).

On American Society of Clinical Oncology (ASCO) Education Council (1/6/20 - 5/6/2023).

Member of ASCO (ASCO career conversations mentor for trainee and early career oncologists (2020 onwards)).

Member of the NETs and endocrine tumours track: ESMO Congress 2025 Scientific Committee.

Faculty member for the EORTC-ESMO-ECCO-ACCR Workshop on Methods in Clinical Cancer Research, 2019, Zeist, Netherlands, and the following year (virtual), and in 2022 and 2023.

Member of European Neuroendocrine Tumour Society (ENETS) advisory Board (2023-2025).

Member of abstract reviewing committee for the 21st Annual ENETS Conference | 13 – 15 March 2024.

Member of European Society for Medical Oncology.

Member of European Neuroendocrine Tumour Society.

Member of European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group.

Member of International Biliary Tract Cancer Collaborators (IBTCC).

Member of International Cholangiocarcinoma Research Network.

National:

Member of UKI Neuroendocrine Tumour Society (Chair of annual conference programme organising committee from 2021-2023 onwards [3 year term]).

Member of National Cancer Research Institute Neuroendocrine Tumour (NCRI NET) subgroup UK (until 2023).

Member of Clinical Practice Committee for UKI NETS (2017-2020).

Aurora (Leadership Foundation for Higher Education) role model for development of women leaders in higher education (until 2019).

Local:

Member of Division of Cancer Sciences, University of Manchester promotions/probations advisory group (2018-present; Chair since 2020).

University of Manchester, Divison of Cancer Sciences research ethics signatory.

Member of Manchester Cancer HPB Pathway Board.

MB, BCh, BAO, B Med Sci, BSc, PhD, FRCP UK, Senior Fellow of the Higher Education Academy (HEA) UK,

Postgraduate Certificate in Higher Education

X (Previously Twitter): @MGMcNamara